Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive palmoplantar hyperkeratosis and congenital alopecia (PPK-CA) is a rare genetic skin disorder characterized by congenital alopecia and palmoplantar hyperkeratosis. It is usually associated with cataracts, progressive sclerodactyly and pseudo-ainhum.
Features include: Alopecia totalis, Facial erythema, Nail dysplasia, and Camptodactyly of finger and 8 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 7 | Alopecia totalis, Facial erythema, Nail dysplasia |
Head and neck |
Biomarker and diagnostic research for autosomal recessive palmoplantar keratoderma and congenital alopecia has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autosomal recessive palmoplantar keratoderma and congenital alopecia.
100 publications have been identified in PubMed for autosomal recessive palmoplantar keratoderma and congenital alopecia. Research spans Review / Meta-Analysis (71%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (5%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 60 | 71% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 9:45 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1
Facial erythema |
Arms and legs | 1 | Camptodactyly of finger |
Eyes | 1 | Developmental cataract |
Age of onset: at birth.
Laboratory research |
14 |
17% |
Disease patterns and progression | 4 | 5% |
Other research | 2 | 2% |
Patient case studies | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
New treatment approaches | 1 | 1% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Sullivan MM (2025). [PMID: 40153327](https://pubmed.ncbi.nlm.nih.gov/40153327/). *Clin Exp Rheumatol*. [Review / Meta-Analysis]
Cornejo-Sanchez DM (2025). [PMID: 40055553](https://pubmed.ncbi.nlm.nih.gov/40055553/). *Eur J Hum Genet*. [Basic Science / Preclinical]
Soodhana D (2025). [PMID: 40416472](https://pubmed.ncbi.nlm.nih.gov/40416472/). *J ASEAN Fed Endocr Soc*. [Case Report / Case Series]
Shah PD (2025). [PMID: 40831349](https://pubmed.ncbi.nlm.nih.gov/40831349/). *Curr Opin Pediatr*. [Review / Meta-Analysis]
Bonniaud V (2025). [PMID: 40546152](https://pubmed.ncbi.nlm.nih.gov/40546152/). *Rev Prat*. [Review / Meta-Analysis]
Verbinnen I (2025). [PMID: 39978342](https://pubmed.ncbi.nlm.nih.gov/39978342/). *Am J Hum Genet*. [Basic Science / Preclinical]
Patel R (2025). [PMID: 40204117](https://pubmed.ncbi.nlm.nih.gov/40204117/). *J Neuroradiol*. [Basic Science / Preclinical]
Kröll-Hermi A (2025). [PMID: 41260215](https://pubmed.ncbi.nlm.nih.gov/41260215/). *Am J Hum Genet*. [Epidemiology / Natural History]